Concepedia

A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial

Sunil V. Rao, Uwe Zeymer, Pamela S. Douglas, Hussein R. Al‐Khalidi, Jingyu Liu, C. Michael Gibson, Robert W. Harrison, Diane S. Joseph, Reinilde Heyrman, Mitchell W. Krucoff

American Heart Journal · 2015 · 45 citations · 11 references

DOI

Concepts

References

11

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Martin St. John Sutton, Marc A. Pfeffer, Theodore Plappert et al. · Circulation · 1994 · 819 citations

, , +17

Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction

Robert H. Jones, Eric J. Velazquez, Robert E. Michler et al. · New England Journal of Medicine · 2009 · 724 citations · Full text

, , +10

Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat

Natali Landa, Liron Miller, Micha S. Feinberg et al. · Circulation · 2008 · 447 citations

, , +17

Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention

JAMA · 2007 · 440 citations · Full text

, , +17

Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction

Scott D. Solomon, Hicham Skali, Nagesh S. Anavekar et al. · Circulation · 2005 · 291 citations

, , +14